Manufacturer
BAYER AG
Contents
Testosterone undecanoate
Indication
Testosterone replacement therapy for male hypogonadism when testosterone deficiency has been confirmed by clinical features & biochemical tests.
Instruction
1 ampoule IM every 10-14 wk, the 1st inj interval may be reduced to a min of 6 wk.
Drug interaction
Increased clearance w/ barbiturates & other enzyme inducers. Increased oxyphenbutazone serum levels. Increased activity of oral anticoagulants. Enhanced blood sugar reducing effects of insulin.
Malaysia
